Avatrombopag, sold under the brand name Doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure.[8][9] It was approved for medical use in the United States in May 2018,[10][11] the European Union in June 2019,[7] and Australia in January 2023.[1]
It acts as a thrombopoietin receptor agonist.[12]
This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.
Lokasi Pengunjung: 18.218.136.90